| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |